Anti-inflammatory properties of antipsychotics via microglia modulations: Are antipsychotics a 'fire extinguisher' in the brain of schizophrenia?

Takahiro Kato, A. Monji, Y. Mizoguchi, S. Hashioka, H. Horikawa, Y. Seki, M. Kasai, H. Kasai, H. Utsumi, Shigenobu Kanba

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Schizophrenia is one of the most severe psychiatric diseases noted for its chronic and often debilitating processes; affecting approximately 1% of the world's population, while its etiology and therapeutic strategies still remain elusive. In the 1950s, the discovery of antipsychotic effects of haloperidol and chlorpromazine shifted the paradigm of schizophrenia. These drugs proved to be antagonists of dopamine D2 receptor (D2R), thus dopamine system dysfunction came to be hypothesized in the pathophysiology of schizophrenia, and D2R antagonism against dopamine neurons has been considered as the primary therapeutic target for schizophrenia. In addition, abnormalities of glutamatergic neurons have been indicated in the pathophysiology of schizophrenia. On the other hand, recent neuroimaging studies have shown that not only dementia but also schizophrenic patients have a significant volume reduction of some specific regions in the brain, which indicates that schizophrenia may involve some neurodegenerative process. Microglia, major sources of various inflammatory cytokines and free radicals such as superoxide and nitric oxide (NO) in the CNS, play a crucial role in a variety of neurodegenerative diseases such as dementia. Recent postmortem and positron emission computed tomography (PET) studies have indicated that activated microglia may be present in schizophrenic patients. Recent in vitro studies have suggested the anti-inflammatory effects of antipsychotics on microglial activation. In this article, we review the anti-inflammatory effects of antipsychotics on microglia, and propose a novel therapeutic hypothesis of schizophrenia from the perspective of microglial modulation.

Original languageEnglish
Pages (from-to)565-574
Number of pages10
JournalMini-Reviews in Medicinal Chemistry
Volume11
Issue number7
DOIs
Publication statusPublished - Jul 11 2011

Fingerprint

Microglia
Antipsychotic Agents
Schizophrenia
Anti-Inflammatory Agents
Brain
Dementia
Emission-Computed Tomography
Dopaminergic Neurons
Chlorpromazine
Haloperidol
Neuroimaging
Superoxides
Neurodegenerative Diseases
Positron-Emission Tomography
Free Radicals
Psychiatry
Dopamine
Nitric Oxide
Therapeutics
Cytokines

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Cite this

Anti-inflammatory properties of antipsychotics via microglia modulations : Are antipsychotics a 'fire extinguisher' in the brain of schizophrenia? / Kato, Takahiro; Monji, A.; Mizoguchi, Y.; Hashioka, S.; Horikawa, H.; Seki, Y.; Kasai, M.; Kasai, H.; Utsumi, H.; Kanba, Shigenobu.

In: Mini-Reviews in Medicinal Chemistry, Vol. 11, No. 7, 11.07.2011, p. 565-574.

Research output: Contribution to journalArticle

Kato, Takahiro ; Monji, A. ; Mizoguchi, Y. ; Hashioka, S. ; Horikawa, H. ; Seki, Y. ; Kasai, M. ; Kasai, H. ; Utsumi, H. ; Kanba, Shigenobu. / Anti-inflammatory properties of antipsychotics via microglia modulations : Are antipsychotics a 'fire extinguisher' in the brain of schizophrenia?. In: Mini-Reviews in Medicinal Chemistry. 2011 ; Vol. 11, No. 7. pp. 565-574.
@article{b6e5cfe0cfb74d729dc19d755cbbb880,
title = "Anti-inflammatory properties of antipsychotics via microglia modulations: Are antipsychotics a 'fire extinguisher' in the brain of schizophrenia?",
abstract = "Schizophrenia is one of the most severe psychiatric diseases noted for its chronic and often debilitating processes; affecting approximately 1{\%} of the world's population, while its etiology and therapeutic strategies still remain elusive. In the 1950s, the discovery of antipsychotic effects of haloperidol and chlorpromazine shifted the paradigm of schizophrenia. These drugs proved to be antagonists of dopamine D2 receptor (D2R), thus dopamine system dysfunction came to be hypothesized in the pathophysiology of schizophrenia, and D2R antagonism against dopamine neurons has been considered as the primary therapeutic target for schizophrenia. In addition, abnormalities of glutamatergic neurons have been indicated in the pathophysiology of schizophrenia. On the other hand, recent neuroimaging studies have shown that not only dementia but also schizophrenic patients have a significant volume reduction of some specific regions in the brain, which indicates that schizophrenia may involve some neurodegenerative process. Microglia, major sources of various inflammatory cytokines and free radicals such as superoxide and nitric oxide (NO) in the CNS, play a crucial role in a variety of neurodegenerative diseases such as dementia. Recent postmortem and positron emission computed tomography (PET) studies have indicated that activated microglia may be present in schizophrenic patients. Recent in vitro studies have suggested the anti-inflammatory effects of antipsychotics on microglial activation. In this article, we review the anti-inflammatory effects of antipsychotics on microglia, and propose a novel therapeutic hypothesis of schizophrenia from the perspective of microglial modulation.",
author = "Takahiro Kato and A. Monji and Y. Mizoguchi and S. Hashioka and H. Horikawa and Y. Seki and M. Kasai and H. Kasai and H. Utsumi and Shigenobu Kanba",
year = "2011",
month = "7",
day = "11",
doi = "10.2174/138955711795906941",
language = "English",
volume = "11",
pages = "565--574",
journal = "Mini-Reviews in Medicinal Chemistry",
issn = "1389-5575",
publisher = "Bentham Science Publishers B.V.",
number = "7",

}

TY - JOUR

T1 - Anti-inflammatory properties of antipsychotics via microglia modulations

T2 - Are antipsychotics a 'fire extinguisher' in the brain of schizophrenia?

AU - Kato, Takahiro

AU - Monji, A.

AU - Mizoguchi, Y.

AU - Hashioka, S.

AU - Horikawa, H.

AU - Seki, Y.

AU - Kasai, M.

AU - Kasai, H.

AU - Utsumi, H.

AU - Kanba, Shigenobu

PY - 2011/7/11

Y1 - 2011/7/11

N2 - Schizophrenia is one of the most severe psychiatric diseases noted for its chronic and often debilitating processes; affecting approximately 1% of the world's population, while its etiology and therapeutic strategies still remain elusive. In the 1950s, the discovery of antipsychotic effects of haloperidol and chlorpromazine shifted the paradigm of schizophrenia. These drugs proved to be antagonists of dopamine D2 receptor (D2R), thus dopamine system dysfunction came to be hypothesized in the pathophysiology of schizophrenia, and D2R antagonism against dopamine neurons has been considered as the primary therapeutic target for schizophrenia. In addition, abnormalities of glutamatergic neurons have been indicated in the pathophysiology of schizophrenia. On the other hand, recent neuroimaging studies have shown that not only dementia but also schizophrenic patients have a significant volume reduction of some specific regions in the brain, which indicates that schizophrenia may involve some neurodegenerative process. Microglia, major sources of various inflammatory cytokines and free radicals such as superoxide and nitric oxide (NO) in the CNS, play a crucial role in a variety of neurodegenerative diseases such as dementia. Recent postmortem and positron emission computed tomography (PET) studies have indicated that activated microglia may be present in schizophrenic patients. Recent in vitro studies have suggested the anti-inflammatory effects of antipsychotics on microglial activation. In this article, we review the anti-inflammatory effects of antipsychotics on microglia, and propose a novel therapeutic hypothesis of schizophrenia from the perspective of microglial modulation.

AB - Schizophrenia is one of the most severe psychiatric diseases noted for its chronic and often debilitating processes; affecting approximately 1% of the world's population, while its etiology and therapeutic strategies still remain elusive. In the 1950s, the discovery of antipsychotic effects of haloperidol and chlorpromazine shifted the paradigm of schizophrenia. These drugs proved to be antagonists of dopamine D2 receptor (D2R), thus dopamine system dysfunction came to be hypothesized in the pathophysiology of schizophrenia, and D2R antagonism against dopamine neurons has been considered as the primary therapeutic target for schizophrenia. In addition, abnormalities of glutamatergic neurons have been indicated in the pathophysiology of schizophrenia. On the other hand, recent neuroimaging studies have shown that not only dementia but also schizophrenic patients have a significant volume reduction of some specific regions in the brain, which indicates that schizophrenia may involve some neurodegenerative process. Microglia, major sources of various inflammatory cytokines and free radicals such as superoxide and nitric oxide (NO) in the CNS, play a crucial role in a variety of neurodegenerative diseases such as dementia. Recent postmortem and positron emission computed tomography (PET) studies have indicated that activated microglia may be present in schizophrenic patients. Recent in vitro studies have suggested the anti-inflammatory effects of antipsychotics on microglial activation. In this article, we review the anti-inflammatory effects of antipsychotics on microglia, and propose a novel therapeutic hypothesis of schizophrenia from the perspective of microglial modulation.

UR - http://www.scopus.com/inward/record.url?scp=79959980999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959980999&partnerID=8YFLogxK

U2 - 10.2174/138955711795906941

DO - 10.2174/138955711795906941

M3 - Article

C2 - 21699487

AN - SCOPUS:79959980999

VL - 11

SP - 565

EP - 574

JO - Mini-Reviews in Medicinal Chemistry

JF - Mini-Reviews in Medicinal Chemistry

SN - 1389-5575

IS - 7

ER -